Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS Kyorin Starts Pivotal Study of Chronic Cough DTx in Japan
June 12, 2026
-
BUSINESS Lotte Biopharma CVC Invests in Swiss ADC Startup
June 12, 2026
-
BUSINESS Ono Seeks Velexbru Nod for CNS Involvement of Malignant Lymphoma
June 12, 2026
-
BUSINESS Ono Files Opdivo for Anaplastic Thyroid Cancer
June 12, 2026
-
REGULATORY Revolade, Bilanoa See First Generics in June Listing; 3 Final AGs on Roster
June 11, 2026
-
REGULATORY Official Hints at Potential Change to Growth Target in Draft Roadmap
June 11, 2026
-
BUSINESS Lilly Warns Against Off-Label Use of Mounjaro
June 11, 2026
-
BUSINESS BMS Seeks Japan Approval for Mezigdomide in Multiple Myeloma
June 11, 2026
-
BUSINESS SanBio Sees Akuugo Expanding to 20-30 Treatment Centers
June 11, 2026
-
BUSINESS Rakuten Medical to Promote President Maeda to CEO
June 11, 2026
-
BUSINESS Metagen Starts Global PI/II Trial of Oral FMT Therapy
June 11, 2026
-
BUSINESS Sumitomo Completes Enrollment for Enzomenib PII Analysis
June 11, 2026
-
BUSINESS Takeda's Entyvio IV Under FDA Review for Pediatric Use
June 11, 2026
-
BUSINESS Japan’s First OTC ED Drug Cialis to Hit Shelves in August
June 11, 2026
-
ACADEMIA Urine-Derived Stem Cells Eyed as New Drug Discovery Tool
June 10, 2026
-
REGULATORY Ishin Proposes Adding Drug, Device Makers to Chuikyo, LDP Wary
June 10, 2026
-
REGULATORY Cabinet Approves Immunization Act Revision to Cover Antibody Drugs
June 10, 2026
-
REGULATORY LDP Lawmakers Seek Routine HPV Vaccinations for Males by April 2027
June 10, 2026
-
BUSINESS Healios Countersues AND Medical over Unpaid Milestone
June 10, 2026
-
REGULATORY LDP Team Seeks Minister-Led AI Task Force at MHLW
June 10, 2026
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…